Standard Biotools Inc (LAB) — Comparison of Productivity to Peers

Standard Biotools Inc 's Productivity vs Peers Comparison

Table 1: Market Cap, Revenue per Employee, Income per Employee for the 12 Months period ended in Q3 2025

COMPANY NAME
TICKER
MARKET CAP
(Millions $)
REVENUE / EMPLOYEE
($) in 12 months
INCOME / EMPLOYEE
($) in 12 months
Standard Biotools Inc
LAB
555 642,366 -634,906
Thermo Fisher Scientific Inc
TMO
216,322 358,492 53,893
Illumina Inc
ILMN
20,770 463,568 75,892
Agilent Technologies inc
A
39,809 378,436 81,397
Bio rad Laboratories Inc
BIO
8,296 318,507 -84,172
Qiagen N v
QGEN
10,162 330,922 14,412
Becton Dickinson And Company
BDX
57,920 295,135 22,676
Olink Holding Ab publ
OLK
3,297 423,653 -79,000
Cytek Biosciences Inc
CTKB
620 796,713 -24,791
Bruker Corporation
BRKR
6,851 293,935 -2,768
Akoya Biosciences Inc
AKYA
68 238,348 -142,742
Astrotech Corp
ASTC
7 43,733 -467,900
Avantor Inc
AVTR
7,615 487,052 -6,089
Harvard Bioscience Inc
HBIO
33 244,363 -151,648
Mettler Toledo International Inc
MTD
28,669 246,362 52,233
Nautilus Biotechnology Inc
NAUT
234 - -872,417
Singular Genomics Systems Inc
OMIC
50 14,032 -454,326
Pressure Biosciences Inc
PBIO
0 124,279 -2,454,139
Quanterix Corporation
QTRX
348 276,200 -203,104
Rapid Micro Biosystems Inc
RPID
164 187,258 -104
Reflect Scientific Inc
RSCF
4 37,091 -396
Revvity Inc
RVTY
11,603 244,641 20,651
Scientific Industries Inc
SCND
7 179,062 -128,908
Telesis Bio Inc
TBIO
0 1,269,273 -4,141,000
10x Genomics Inc
TXG
1,940 507,929 -16,863
Pacific Biosciences Of California Inc
PACB
638 268,299 -875,885
SUBTOTAL 415,423 338,715 33,623

What this table shows: Productivity metrics illustrate how effectively a company converts workforce and capital into value. Higher Revenue per Employee and Net Income per Employee generally reflect stronger operating efficiency and business scalability. First row shows Company's Productivity, followed by it's corporate peers. Click any company name in the table to view its complete financial analysis and comparison.


Standard Biotools Inc 's Financial Strength vs Peers Comparison

Table 2: Quick Ratio, Working Capital, Debt/Equity, Asset Turnover

COMPANY NAME
TICKER
QUICK
(Ratio)
WORKING CAPITAL
(Ratio)
DEBT / EQUITY
(Ratio)
ASSET TURNOVER
(Ratio)
Standard Biotools Inc
LAB
3.00 5.18 0.00 0.23
Thermo Fisher Scientific Inc
TMO
0.40 1.71 0.68 0.44
Illumina Inc
ILMN
0.10 1.69 0.85 0.69
Agilent Technologies inc
A
0.76 2.16 0.56 0.56
Bio rad Laboratories Inc
BIO
2.99 5.73 0.18 0.26
Qiagen N v
QGEN
2.12 3.61 0.39 0.34
Becton Dickinson And Company
BDX
0.18 1.20 0.70 0.40
Olink Holding Ab publ
OLK
2.18 4.75 - 0.28
Cytek Biosciences Inc
CTKB
3.96 5.69 0.00 0.41
Bruker Corporation
BRKR
0.14 1.66 1.10 0.41
Akoya Biosciences Inc
AKYA
0.72 1.56 8.09 0.62
Astrotech Corp
ASTC
8.24 9.86 - 0.05
Avantor Inc
AVTR
0.16 1.13 0.68 0.54
Harvard Bioscience Inc
HBIO
0.11 0.81 1.31 0.95
Mettler Toledo International Inc
MTD
0.03 1.06 - 1.18
Nautilus Biotechnology Inc
NAUT
16.65 17.00 - -
Singular Genomics Systems Inc
OMIC
8.30 9.25 0.05 0.01
Pressure Biosciences Inc
PBIO
0.00 0.02 - 0.45
Quanterix Corporation
QTRX
4.58 6.03 - 0.32
Rapid Micro Biosystems Inc
RPID
2.52 4.28 0.08 0.36
Reflect Scientific Inc
RSCF
2.68 5.10 - 0.65
Revvity Inc
RVTY
1.32 2.83 0.42 0.23
Scientific Industries Inc
SCND
- 4.88 - 0.76
Telesis Bio Inc
TBIO
0.76 2.63 - 0.26
10x Genomics Inc
TXG
3.61 5.11 - 0.67
Pacific Biosciences Of California Inc
PACB
5.26 6.83 3.72 0.16
SUBTOTAL 0.46 1.73 0.64 0.43

Standard Biotools Inc — Financial Strength vs Peers (Peer Comparison)

This table compares Quick Ratio, Working Capital, Debt-to-Equity, and Asset Turnover for Standard Biotools Inc and its closest competitors. Only the top peers are shown publicly to ensure fast loading and a clear overview.

COMPANY NAME
TICKER
QUICK
Ratio
WORKING CAPITAL
Ratio
DEBT / EQUITY
Ratio
ASSET TURNOVER
Ratio
Standard Biotools Inc
LAB
3.00 5.18 0.00 0.23
Thermo Fisher Scientific Inc
TMO
0.40 1.71 0.68 0.44
Illumina Inc
ILMN
0.10 1.69 0.85 0.69
Agilent Technologies inc
A
0.76 2.16 0.56 0.56
Bio rad Laboratories Inc
BIO
2.99 5.73 0.18 0.26
Qiagen N v
QGEN
2.12 3.61 0.39 0.34
20 additional peer companies available in the full Financial Strength Comparison dataset.
Unlock Full Competitor List

What this table shows: Financial Strength ratios measure short-term liquidity (Quick Ratio, Working Capital), leverage (Debt/Equity), and operational utilization (Asset Turnover). These indicators highlight how well management allocates resources and maintains financial stability.

Standard Biotools Inc 's Underlying Financial Totals (Revenue, Income, Employees) vs Peers Comparison

Table 3: Revenue (TTM), Net Income (TTM), Net Margin, Employees, ending Q3 2025

COMPANY NAME
TICKER
REVENUE (TTM)
Millions $
NET INCOME (TTM)
Millions $
NET MARGIN
(%)
NUMBER OF EMPLOYEES
Standard Biotools Inc
LAB
129.8 -128.3 -98.84% 202
Thermo Fisher Scientific Inc
TMO
43,736 6,575 15.03% 122,000
Illumina Inc
ILMN
4,288 702 16.37% 9,250
Agilent Technologies inc
A
6,774 1,457 21.51% 17,900
Bio rad Laboratories Inc
BIO
2,558 -676 -26.43% 8,030
Qiagen N v
QGEN
1,919 84 4.36% 5,800
Becton Dickinson And Company
BDX
21,840 1,678 7.68% 74,000
Olink Holding Ab publ
OLK
169 -32 -18.65% 400
Cytek Biosciences Inc
CTKB
202 -6 -3.11% 254
Bruker Corporation
BRKR
2,506 -24 -0.94% 8,525
Akoya Biosciences Inc
AKYA
79 -48 -59.89% 333
Astrotech Corp
ASTC
1 -14 -1069.89% 30
Avantor Inc
AVTR
6,575 -82 -1.25% 13,500
Harvard Bioscience Inc
HBIO
87 -54 -62.06% 355
Mettler Toledo International Inc
MTD
3,942 836 21.2% 16,000
Nautilus Biotechnology Inc
NAUT
- -63 - 72
Singular Genomics Systems Inc
OMIC
3 -86 -3237.88% 190
Pressure Biosciences Inc
PBIO
2 -37 -1974.71% 15
Quanterix Corporation
QTRX
130 -96 -73.54% 471
Rapid Micro Biosystems Inc
RPID
31 0 -0.06% 163
Reflect Scientific Inc
RSCF
2 0 -1.07% 45
Revvity Inc
RVTY
2,813 237 8.44% 11,500
Scientific Industries Inc
SCND
9 -6 -71.99% 50
Telesis Bio Inc
TBIO
14 -46 -326.25% 11
10x Genomics Inc
TXG
639 -21 -3.32% 1,259
Pacific Biosciences Of California Inc
PACB
154 -504 -326.46% 575
SUBTOTAL 98,474 9,775 9.93% 290,728

What this table shows: These totals provide the raw financial fundamentals behind the productivity, Revenue and Income per Employee ratios above. Revenue, Net Income, and Employee counts reflect the company’s scale, profitability, and workforce size. TTM refers to trailing twelve months.


Methodology & Data Source: Market Capitalization is computed from the latest available share price (delayed up to 15 minutes, depending on exchange rules) multiplied by the company’s diluted share count as reported in its filings. Revenue and Net Income figures used to calculate Revenue per Employee and Net Income per Employee are sourced directly from quarterly and annual financial statements submitted to the U.S. Securities and Exchange Commission (SEC). Employee counts are taken from the most recent Form 10-K or 10-Q disclosure and may be updated by companies in subsequent SEC submissions. All fundamentals are processed through CSIMarket.com’s XBRL normalization pipeline, which standardizes reported values across all issuers and periods.

Data lineage: SEC Filings → XBRL Extraction → CSIMarket Normalization → Productivity Metrics.

This table is one of the productivity comparisons available for Standard Biotools Inc . Across CSIMarket, we provide nine related comparison tables showing how Standard Biotools Inc performs against its Peers, including additional breakdowns visible through our main navigation bar under:
Stocks → Peers.

This page compares Standard Biotools Inc to its Peers based on Productivity (Market Cap, Revenue per Employee, and Net Income per Employee).

• For a deeper productivity comparison against its industry peers, visit
Standard Biotools Inc Productivity vs. Industry

• To review historical productivity trends for this company, including long-term changes in Revenue per Employee and Net Income per Employee, visit
Standard Biotools Inc Productivity History


Page last updated:

CSIMarket data powering this analysis is available across multiple delivery channels:
Data Downloads (CSV / Excel)
API & Programmatic Data Access
Enterprise Data Licensing
AI Training & Model Development License
Marketplace Distribution Options

All CSIMarket datasets are designed for analytical workflows, financial modeling, academic research, and AI/ML applications requiring normalized, reliable, and longitudinal financial time series.

To download the tables, please subscribe.